Apolipoprotein AI mimetic peptides: possible new agents for the treatment of atherosclerosis.
about
Oxpholipin 11D: an anti-inflammatory peptide that binds cholesterol and oxidized phospholipidsTomatoes, lysophosphatidic acid, and the small intestine: new pieces in the puzzle of apolipoprotein mimetic peptides?The 5A apolipoprotein A-I mimetic peptide displays antiinflammatory and antioxidant properties in vivo and in vitro.Trans-splicing into highly abundant albumin transcripts for production of therapeutic proteins in vivo.5A apolipoprotein mimetic peptide promotes cholesterol efflux and reduces atherosclerosis in mice.Structure/function relationships of apolipoprotein a-I mimetic peptides: implications for antiatherogenic activities of high-density lipoprotein.HDL-replacement therapy: mechanism of action, types of agents and potential clinical indications.5A, an apolipoprotein A-I mimetic peptide, attenuates the induction of house dust mite-induced asthmaA new HDL mimetic peptide that stimulates cellular cholesterol efflux with high efficiency greatly reduces atherosclerosis in miceApolipoprotein mimetic peptides: Mechanisms of action as anti-atherogenic agents.An apolipoprotein A-I mimetic peptide designed with a reductionist approach stimulates reverse cholesterol transport and reduces atherosclerosis in mice.A novel apolipoprotein C-II mimetic peptide that activates lipoprotein lipase and decreases serum triglycerides in apolipoprotein E-knockout miceNew kids on the block: the emerging role of apolipoproteins in the pathogenesis and treatment of asthma.Helix stabilization of amphipathic peptides by hydrocarbon stapling increases cholesterol efflux by the ABCA1 transporter.Apolipoprotein mimetic peptides: a new approach for the treatment of asthma.Apolipoprotein A-I attenuates ovalbumin-induced neutrophilic airway inflammation via a granulocyte colony-stimulating factor-dependent mechanism.Hydrophobic amino acids in the hinge region of the 5A apolipoprotein mimetic peptide are essential for promoting cholesterol efflux by the ABCA1 transporter.Asymmetry in the lipid affinity of bihelical amphipathic peptides. A structural determinant for the specificity of ABCA1-dependent cholesterol efflux by peptides.Adenoviral expression of human lecithin-cholesterol acyltransferase in nonhuman primates leads to an antiatherogenic lipoprotein phenotype by increasing high-density lipoprotein and lowering low-density lipoproteinPotential biomarkers in the sera of breast cancer patients from bahawalpur, pakistan.Lecithin cholesterol acyltransferase: an anti- or pro-atherogenic factor?A fluorescence method to detect and quantitate sterol esterification by lecithin:cholesterol acyltransferaseMC-PPEA as a new and more potent inhibitor of CLP-induced sepsis and pulmonary inflammation than FK866.An apoA-I mimetic peptide increases LCAT activity in mice through increasing HDL concentration.Apolipoprotein A-II: still second fiddle in high-density lipoprotein metabolism?Structural properties of apolipoprotein A-I mimetic peptides that promote ABCA1-dependent cholesterol efflux.
P2860
Q28752575-CAE2B7A4-D994-4068-B0F8-868A3C9894C9Q33356762-3A74517C-B2B8-4B56-88EA-37AE2A046B7DQ33687423-EB54E7E0-2659-446F-821A-836EF90B7664Q33713295-E7CE37E8-8D34-453B-92F5-AA63087AF033Q34035255-6DA1E6B3-CB38-44A9-9B37-EBE871A73A39Q34144449-1B83877D-D7C9-49FF-ACE2-55245766B2F1Q34181607-6D06CF52-896A-4E31-B311-389EF39AEEF1Q34449116-4C2DF599-9C73-4F0E-91CD-A757D3091458Q34559952-97DB0D52-631C-47D5-A86F-02DD01C9F67EQ34594140-BD4B903D-7F69-4174-93A8-AB05B511D835Q34851167-AFE7EE6D-FCF8-402C-A056-88FC3AA8410FQ34946523-7759DB2A-8475-4BD8-9E32-1D96D677FF49Q35267682-B72AA7B9-18A1-4A48-BE81-AC053D9F22D7Q35660283-8EED1D1A-2208-4FA9-A2F6-4FE788EECC14Q35815986-F95B697A-35CF-4BC2-833A-51178C18D0B5Q36176942-A40A6332-F237-4F10-AC49-2FC57F1669AAQ36497600-B2517F7A-2C65-4C66-952A-4755E3198FAFQ36973725-BDDA98C7-F76B-480A-9F30-1AA7F6FF399FQ36989495-44E6B315-A0F4-4218-81AC-1BCA899C7562Q37218912-F2027A7F-A504-4109-8C68-EE51E719A67AQ37224981-50A27E28-7F10-4AE7-983C-ED1523504140Q37293943-596BB8D9-E053-4304-BC55-A139AB479B88Q37691630-652A478B-4E5A-4F21-9F69-586908799A86Q39812837-F9E9BE82-0B4E-4408-9839-4C6F3ECBF209Q42791504-E909E106-D4E5-4235-B893-4A1A927BB59DQ49309273-032F93F4-A606-4248-AC08-6323EB31657D
P2860
Apolipoprotein AI mimetic peptides: possible new agents for the treatment of atherosclerosis.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Apolipoprotein AI mimetic pept ...... treatment of atherosclerosis.
@ast
Apolipoprotein AI mimetic pept ...... treatment of atherosclerosis.
@en
type
label
Apolipoprotein AI mimetic pept ...... treatment of atherosclerosis.
@ast
Apolipoprotein AI mimetic pept ...... treatment of atherosclerosis.
@en
prefLabel
Apolipoprotein AI mimetic pept ...... treatment of atherosclerosis.
@ast
Apolipoprotein AI mimetic pept ...... treatment of atherosclerosis.
@en
P2093
P1476
Apolipoprotein AI mimetic pept ...... treatment of atherosclerosis.
@en
P2093
Alan T Remaley
Amar A Sethi
Marcelo Amar
Robert D Shamburek
P304
P577
2007-03-01T00:00:00Z